Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigón, Lorena, Vázquez-Morón, Sonia, Berenguer, Juan, González-García, Juan, Jiménez-Sousa, Ma Ángeles, Guardiola, Josep M., Crespo, Manuel, de Los Santos, Ignacio, Von Wichmann, Miguel A., Carrero, Ana, Yélamos, María Belén, Gómez, Julián, Resino, Salvador, Martínez, Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704069/
https://www.ncbi.nlm.nih.gov/pubmed/31434968
http://dx.doi.org/10.1038/s41598-019-48592-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704069/
https://www.ncbi.nlm.nih.gov/pubmed/31434968
http://dx.doi.org/10.1038/s41598-019-48592-5

Ejemplares similares